Results 51 to 60 of about 2,403 (210)

Epidemiology of paediatric renal stone disease: a 22-year single centre experience in the UK [PDF]

open access: yes, 2017
BACKGROUND: Whilst still rare, the incidence of paediatric stone disease is increasing in developed countries and it is important to evaluate the aetiology.
Bockenhauer, D   +5 more
core   +1 more source

Probiotic Intervention in the Management of Urolithiasis: A Pathway to Gut Microbiome Modulation

open access: yesAdvanced Gut &Microbiome Research, Volume 2026, Issue 1, 2026.
Urolithiasis, or kidney stone disease, is a chronic, recurrent disorder that significantly impacts renal health. Despite the availability of pharmacological and dietary strategies, recurrence of urolithiasis remains a major challenge. Emerging research highlights the gut–kidney axis as a critical mediator in kidney stone pathophysiology, particularly ...
Roopa Shri Balakrishnan   +3 more
wiley   +1 more source

Tip 1 Glikojen Depo Hastalığı Olan Bir Çocukta Distal Renal Tübüler Disfonksiyon ve Kalsiyum Taş Hastalığı: Vaka Sunumu

open access: yesTurkish Journal of Nephrology, 2019
Type 1 glycogen storage disease is caused by glucose-6-phosphatase deficiency and nephrolithiasis is the most common renal complication. Although urate stones are the most common stone type, metabolic alterations favoring calcium nephrolithiasis has also
Yeşim ÖZTÜRK   +5 more
doaj   +2 more sources

Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases

open access: yesBMC Urology, 2023
Background Nephrolithiasis as a feature of rheumatologic diseases is under recognized. Understanding presenting features, diagnostic testing is crucial to proper management.
Omar Osman   +3 more
doaj   +1 more source

Alkali replacement raises urinary citrate excretion in patients with topiramate‐induced hypocitraturia [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2015
AimsThe aims of this study were to assess (1) the magnitude and temporality of decreased urinary citrate excretion in patients just starting topiramate and (2) the effect of alkali replacement on topiramate‐induced hypocitraturia.MethodsStudy 1 was a prospective, non‐intervention study in which patients starting topiramate for headache remediation ...
R Allan, Jhagroo   +2 more
openaire   +2 more sources

Preventive treatment of nephrolithiasis with alkali citrate—a critical review [PDF]

open access: yes, 2018
Using the keywords "urolithiasis and citrate treatment”, "nephrolithaisis and citrate treatment”, "kidney stones and citrate treatment”, a Medline search revealed 635 articles published between 1 January 1966 and 1 December 2004. For the present analysis,
Hess, B., Mattle, D.
core  

Transurethral Approach for Management of Large Stone Formed on Staples in a Female Patient With Orthotopic Neobladder Assisted by Transurethral Amplatz Sheath and LithoClast Trilogy

open access: yesCase Reports in Urology, Volume 2026, Issue 1, 2026.
Bladder stones occurring in orthotopic neobladders are remote late complications with a reported incidence of 5%. They can be managed with open, endoscopic, or robotic‐assisted approaches. A transurethral endoscopic approach is usually offered for smaller stone burdens, while larger stones are often treated by a percutaneous endoscopic or open approach.
Theodora Maria Zavos   +6 more
wiley   +1 more source

Metabolic assessment of elderly men with urolithiasis

open access: yesClinics, 2012
OBJECTIVE: To assess the presence of metabolic disorders in elderly men with urolithiasis. METHODS: We performed a case-control study. The inclusion criteria were as follows: (1) men older than 60 years of age and either (2) antecedent renal colic or an ...
Celso Heitor Freitas Junior   +4 more
doaj   +1 more source

Hypocitraturia Contributing to Nephrolithiasis in a Patient with CYP24A1 Gene Mutation [PDF]

open access: yesAACE Clinical Case Reports, 2018
ABSTRACT: Objective: There have been several case reports of hypercalcemia due to mutation in CYP24A1, which encodes an enzyme that controls the catabolism of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D to inactive forms. These patients develop nephrolithiasis, nephrocalcinosis, and eventually renal insufficiency.
Mohamed K.M. Shakir, MD   +4 more
openaire   +2 more sources

Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list [PDF]

open access: yes, 2017
Risk factors for low urinary citrate excretion were assessed in 34 consecutive male recurrent idiopathic calcium stone formers (RCSF) who collected two 24-h urines while on free-choice diet.
Ackermann, D.   +4 more
core  

Home - About - Disclaimer - Privacy